Common Cold Treatment

Project Leader:
Krister Tano

Affiliation:
Department of Clinical science, Otorhinolaryngology, Sunderby Hospital

Brief Description:
At times, there is no way to avoid a cold's punch knocking most of us out for a few days to a couple of weeks!

Two or even three bouts of the cold during a season are not unusual and most of us suffer through with various drugs to alleviate the symptoms. The misery has always prompted a need for an effective product to limit the cause rather than just the symptoms.

Dr. Krister Tano has found a safe and effective compound that can help limit the effects of common cold. The product contains an enzyme found in several consumer products today and have been safely used by millions of consumers every day, and is intended to be delivered as a spray that delivers an effective dose. Preliminary preclinical testing has shown promising effects and clinical trials are planned to start in 2011.

Presently Dr. Tano and his team are collating their preclinical data of this novel application of a compound with positive known safety profile.

UBI AB is dedicated to help researchers bring their innovations to the market and believe that Dr. Tano has a potential hit for the consumers.